Simonsson Moa, Wallentin Lars, Alfredsson Joakim, Erlinge David, Hellström Ängerud Karin, Hofmann Robin, Kellerth Thomas, Lindhagen Lars, Ravn-Fischer Annica, Szummer Karolina, Ueda Peter, Yndigegn Troels, Jernberg Tomas
Department of Clinical Sciences, Danderyds Hospital, Karolinska Institutet, Stockholm, Sweden.
Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
Eur Heart J. 2020 Feb 14;41(7):833-843. doi: 10.1093/eurheartj/ehz593.
To describe the time trends of in-hospital and out-of-hospital bleeding parallel to the development of new treatments and ischaemic outcomes over the last 20 years in a nationwide myocardial infarction (MI) population.
Patients with acute MI (n = 371 431) enrolled in the SWEDEHEART registry from 1995 until May 2018 were selected and evaluated for in-hospital bleeding and out-of-hospital bleeding events at 1 year. In-hospital bleeding increased from 0.5% to a peak at 2% 2005/2006 and thereafter slightly decreased to a new plateau around 1.3% by the end of the study period. Out-of-hospital bleeding increased in a stepwise fashion from 2.5% to 3.5 % in the middle of the study period and to 4.8% at the end of the study period. The increase in both in-hospital and out-of-hospital bleeding was parallel to increasing use of invasive strategy and adjunctive antithrombotic treatment, dual antiplatelet therapy (DAPT), and potent DAPT, while the decrease in in-hospital bleeding from 2007 to 2010 was parallel to implementation of bleeding avoidance strategies. In-hospital re-infarction decreased from 2.8% to 0.6% and out-of-hospital MI decreased from 12.6% to 7.1%. The composite out-of-hospital MI, cardiovascular death, and stroke decreased in a similar fashion from 18.4% to 9.1%.
During the last 20 years, the introduction of invasive and more intense antithrombotic treatment has been associated with an increase in bleeding events but concomitant there has been a substantial greater reduction of ischaemic events including improved survival.
描述在过去20年全国范围内心肌梗死(MI)人群中,与新治疗方法的发展以及缺血性结局并行的院内和院外出血的时间趋势。
选取1995年至2018年5月纳入瑞典心脏注册研究(SWEDEHEART registry)的急性心肌梗死患者(n = 371431),并对其1年时的院内出血和院外出血事件进行评估。院内出血从0.5%增加至2005/2006年的峰值2%,此后略有下降,到研究期末降至约1.3%的新平台期。院外出血在研究中期从2.5%逐步增加至3.5%,在研究期末增至4.8%。院内和院外出血的增加与侵入性策略及辅助抗栓治疗、双联抗血小板治疗(DAPT)和强效DAPT使用的增加并行,而2007年至2010年院内出血的减少与出血避免策略的实施并行。院内再梗死从2.8%降至0.6%,院外心肌梗死从12.6%降至7.1%。院外心肌梗死、心血管死亡和卒中的复合终点以类似方式从18.4%降至9.1%。
在过去20年中,侵入性和更强化抗栓治疗的引入与出血事件增加相关,但与此同时,包括生存率提高在内的缺血性事件有更大幅度的减少。